Skip to main content
Tech.euFundingExplorerBeta

Epitomee

Epitomee Medical is a drug-free, self-administered shapeshifting capsule, for inducing weight loss and preventing diabetes

Epitomee has raised €7.1M across 1 funding round from 1 investor, most recently a round in Apr 2019. Based in Caesarea, Israel; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€7.1M
€7,120,605
Funding rounds
1
Investors
1
distinct backers
Active since
2019-04
latest 2019-04

Funding by year

EUR raised per year
Epitomee — funding by year — interactive chart.
Data table
Epitomee — funding by year
2019€7.1M

Signals

High confidence
Raise-next likelihood6
base rate 30% for Other
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2019-04-01Other€7.1MXT Hi-TechView deal →

Investors

1

Related news

Similar companies

same sector or country

Global coverage: FundingData